Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2017-05-16 | 2017-07-13 | 10424 |
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-12-18 | 2021-01-26 | 130407 |
| APO-MELOXICAM | 15MG | TABLET | Resolved | 2020-12-28 | 2021-02-01 | 130713 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-01-29 | 2021-02-23 | 132724 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-03-05 | 2021-04-12 | 135167 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-09 | 2021-05-17 | 137257 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-01 | 2024-02-09 | 203542 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-22 | 2023-12-08 | 204993 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-11-10 | 2023-12-08 | 209926 |
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2018-08-27 | 2019-05-21 | 59302 |
| APO-MELOXICAM | 15MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229422 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-06-27 | 2025-03-13 | 231487 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-08-29 | 2025-03-21 | 236240 |
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2024-09-12 | 2024-10-11 | 237357 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-30 | 2021-05-17 | 138349 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-12-17 | 2022-03-29 | 151345 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-02-02 | 2024-06-27 | 218379 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-04-12 | 2024-06-27 | 224987 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-04-26 | 2025-03-07 | 226348 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-27 | 247469 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 75MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-10 | 247472 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247466 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247462 |